Minimal residual disease quantification in patients with acute myeloid leukaemia and inv(16)/CBFB-MYH11 gene fusion

British Journal of Haematology

Volumn 118, Issue 2, 2002, Pages 411-418

  Van Der Reijden, Bert A ^a,c   Simons, Annet ^b,c   Luiten, Erna ^a   Van Der Poel, Sonja C ^a   Hogenbirk, Pauline E ^a   Tönnissen, Evelyn ^c   Valk, Peter J M ^a   Löwenberg, Bob ^a   De Greef, Georgine E ^a   Breuning, Martijn H ^b   Jansen, Joop H ^a,c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

CBFB MYH11; inv(16); Leukaemia; MRD quantification; Real time PCR

Indexed keywords

AMSACRINE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; GEMTUZUMAB OZOGAMICIN; GENOMIC DNA; HYBRID PROTEIN; IDARUBICIN; MITOXANTRONE; PROTEIN CBFB; PROTEIN MYH11; RNA; UNCLASSIFIED DRUG; VALSPODAR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BLOOD; BONE MARROW; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CELL COUNT; CHROMOSOME 16; CHROMOSOME INVERSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA DETERMINATION; DRUG EFFECT; FEMALE; FOLLOW UP; GENE EXPRESSION; GENE FUSION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MALE; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SAMPLING;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ARTIFICIAL GENE FUSION; CHROMOSOMES, HUMAN, PAIR 16; FEMALE; HUMANS; INVERSION, CHROMOSOME; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; ONCOGENE PROTEINS, FUSION; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0036042008     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03738.x     Document Type: Article

References (21)

1. Induction of the PML protein by interferons in normal and APL cells
2. Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelogenous leukemia
3. Chromosome 16 and bone-marrow eosinophilia
4. Molecular remission of Philadelphia/bcr-abl-positive acute myeloid leukaemia after treatment with anti-CD33 calicheamicin conjugate (gemtuzumab ozogamicin, CMA-676)
5. Detection of minimal residual disease in acute myelomonocytic leukemia with abnormal marrow eosinophils by nested polymerase chain reaction with allele specific amplification
6. Detection and quantification of CBFB/MYH11 fusion transcripts in patients with inv(16)-positive acute myeloblastic leukemia by real-time RT-PCR
7. Competitive CBFbeta/MYH11 reverse-transcriptase polymerase chain reaction for quantitative assessment of minimal residual disease during postremission therapy in acute myeloid leukemia with inversion (16): A pilot study
8. Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16;16) has a favorable prognosis
9. The acute promyelocytic leukaemia-associated PML gene is induced by interferon
10. Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association
11. Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia
12. Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia
13. Graft-versus-lymphoma effect of donor leucocyte infusion shown by real-time quantitative PCR analysis of t(14;18)
14. Quantification of CBFbeta/MYH11 fusion transcript by real time RT-PCR in patients with INV(16) acute myeloid leukemia
15. Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR
16. Detection of the chromosome 16 CBF beta-MYH11 fusion transcript in myelomonocytic leukemias
17. RT-PCR diagnosis of patients with acute nonlymphocytic leukemia and inv(16)(p13q22) and identification of new alternative splicing in CBFB-MYH11 transcripts
18. Acute leukemias with structurally altered core binding factor subunits t(8;21), inv(16), t(12;21), 27-28 June 1997 Rotterdam. The Netherlands
19. Genomic acute myeloid leukemia-associated inv(16)(p13q22) breakpoints are tightly clustered
20. Identification of a novel CBFB-MYH11 transcript: Implications for RT-PCR diagnosis
21. Detection of CBFB/MYH11 transcripts in patients with inversion and other abnormalities of chromosome 16 at presentation and remission